WS #5660

The dominant signal in this window is a significant de-escalation in the Iran-US conflict, directly countering the previous bullish oil price thesis. Multiple high-priority sources (jetstream.bsky.priority, alpaca.news, Axios via jetstream) report that President Trump has extended the ceasefire with Iran, delaying potential attacks after a request from Pakistani leaders, and has given Iran a 3-5 day deadline to present a unified proposal. This is corroborated by a Bloomberg report via jetstream stating 'TRUMP EXTENDS TRUCE WITH TALKS IN LIMBO' and a New York Post exclusive via alpaca.news indicating a second round of talks is possible as soon as Friday. This development dampens the immediate risk of a Strait of Hormuz closure and reduces the bullish pressure on oil prices and energy stocks, acting as a counter-signal to the previous escalation narrative. Concurrently, a bearish signal for oil supply emerges from Benzinga, where Scott Bessent states Iranian oil wells will be shut 'in a matter of days' as US blockade chokes Kharg storage capacity, which could provide some offsetting support to oil prices if realized, but the primary market-moving information is the geopolitical de-escalation. In technology, there are specific, actionable signals for MAG7 tickers. Google Cloud has signed a multi-billion-dollar deal with Mira Murati's Thinking Machines Lab for AI infrastructure powered by Nvidia GB300 chips, as reported by jetstream.bsky.priority. Furthermore, jetstream reports that Marvell Technology ($MRVL) shares jumped as Google seeks its AI chips for diversification beyond Broadcom, indicating a potential strategic shift in Google's custom silicon supply chain. This is a bullish signal for $MRVL and reinforces the $GOOGL-$NVDA partnership narrative. Separately, Broadcom ($AVGO) announced an expanded collaboration with Google Cloud on their new Cloud Network Insights service, with the stock up 1.44% premarket. These developments highlight continued AI infrastructure investment and partnership dynamics. Other notable signals include a Medicare delay for GLP-1 coverage plan, with an interim program extended, as reported by Seeking Alpha, which could dampen near-term demand expectations for Novo Nordisk ($NVO) and Eli Lilly ($LLY) weight-loss drugs. Additionally, there is a bearish analyst note on Apple ($AAPL) from Seeking Alpha, rating it a Sell due to elevated multiples and AI execution concerns amid leadership transition, providing a specific MAG7 counter-narrative to any broader tech strength. Several analyst price target changes (e.g., Synchrony Financial, Quest Diagnostics) are routine and low significance.